|
Maximising Impact of Disease Modifying Antirheumatic Drugs in Rheumatoid Arthritis with the Use of Biomarkers (SQUEEZE)
Third-party funded project |
Project title |
Maximising Impact of Disease Modifying Antirheumatic Drugs in Rheumatoid Arthritis with the Use of Biomarkers (SQUEEZE) |
Principal Investigator(s) |
De Geest, Sabina M.
|
Project Members |
Kocher, Agnes
|
Organisation / Research unit |
Departement Public Health / Institut für Pflegewissenschaft, Departement Public Health / Pflegewissenschaft (De Geest) |
Department |
Departement Public Health |
Project start |
01.01.2023 |
Probable end |
31.12.2027 |
Status |
Active |
Abstract |
The work programme proposed by the SQUEEZE consortium is a truly interrelated collaboration of leading centres in Europe that have come together for synergy and added value for addressing the objectives in a way that each one alone would not be able to. Within SQUEEZE WP#8, we will develop a novel eHealth-facilitated care model which includes personalised digital biomarkers to increase DMARDs effectiveness through optimized patient’s medication adherence and patient/clinician’s shared decision making. The participative and systematic approach has promising potential to improve the health outcomes of this population and – if proven effective – be a game changer in the lives of people with RA. |
Financed by |
Commission of the European Union
|
|
|
|
MCSS v5.8 PRO. 0.429 sec, queries - 0.000 sec
©Universität Basel | Impressum
| |
20/04/2024
Research Database / FORSCHUNGSDATENBANK
|